Noventra Pharma Tirzepatide 30mg Compound peptide Vial – Dual GLP-1/GIP Agonist
Weight Management • Appetite Control • Metabolic Health
Dual GLP-1 / GIP Receptor Agonist
Noventra Pharma Tirzepatide 30mg is a premium compound peptide formulated as a dual GLP-1 and GIP receptor agonist. Tirzepatide has gained significant attention within the wellness and metabolic research space for its potential role in supporting appetite regulation, glucose metabolism, and weight management protocols under professional supervision.
Manufactured to high-quality standards, this 30mg peptide vial is designed for precision handling, stability, and consistency.
Key Features & Potential Benefits
- Dual GLP-1 & GIP receptor activity
- May assist with appetite control and reduced food cravings
- Commonly researched for metabolic and weight management support
- Potential support for blood glucose regulation
- Long-acting peptide profile
- High-purity compounded formulation
- Securely sealed vial for product integrity.
Disclaimer
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPRA) for human or animal use.
Not for human consumption or medical use. Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.
